U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06831474) titled 'Excretion of Rivaroxaban in Human Breast Milk' on Feb. 12.
Brief Summary: The purpose of this study is to investigate the distribution of rivaroxaban into human milk at both therapeutic and prophylactic doses, and over time with repeated dosing.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Postpartum
VTE Prophylaxis
VTE (Venous Thromboembolism)
Rivaroxaban
Breastfeeding
Breast Milk Collection
Intervention:
DRUG: Rivaroxaban 10 MG Oral Tablet
10mg rivaroxaban daily
DRUG: Rivaroxaban 20 MG Oral Tablet
20mg rivaroxaban daily
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Thomas Jefferson University
Info...